| | | | | |
FATE Fate Therapeutics, Inc. | €2,2062 | -2,48 % | €273,76M | €752,08K | |
| €36,4052 | +1,57 % | €273,69M | €13,73K | |
MLP Maui Land & Pineapple Co. | €13,9110 | +0,81 % | €273,59M | €8,73K | |
NMRA Neumora Therapeutics, Inc. Common Stock | €1,4205 | +8,22 % | €273,58M | €611,74K | |
GALT Galectin Therapeutics Inc. | €3,0309 | +0,00 % | €273,44M | €259,78K | |
NREF NexPoint Real Estate Finance, Inc. | €14,8349 | +1,12 % | €273,42M | €24,63K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | €9,3344 | -0,09 % | €273,16M | €3,36K | |
| €2,7718 | +0,00 % | €272,94M | €309,59K | |
EFR Eaton Vance Senior Floating-Rate Fund | €9,1963 | +0,00 % | €272,78M | €94,86K | |
SMTI Sanara MedTech Inc. Common Stock | €29,4885 | +0,44 % | €272,51M | €254,53K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | €9,1013 | +0,07 % | €272,26M | €12,70K | |
ALTO Alto Ingredients, Inc. Common Stock | €3,6526 | +0,24 % | €271,94M | €1,10M | |
RNGT Range Capital Acquisition Corp II Class A Ordinary Shares | €8,7559 | -0,10 % | €271,58M | €7,771 | |
AFB Alliance National Municipal Income Fund, Inc. | €9,4812 | -0,54 % | €271,54M | €96,34K | |
SSP The E.W. Scripps Company | €2,8496 | +1,23 % | €271,26M | €226,33K | |
